123 results on '"Andrade, Bruno B."'
Search Results
2. Impact of Xpert MTB/RIF implementation in tuberculosis case detection and control in Brazil: a nationwide intervention time-series analysis (2011–2022)
- Author
-
Villalva-Serra, Klauss, Barreto-Duarte, Beatriz, Miguez-Pinto, João P., Queiroz, Artur T.L., Rodrigues, Moreno M., Rebeiro, Peter F., Amorim, Gustavo, Cordeiro-Santos, Marcelo, Sterling, Timothy R., Araújo-Pereira, Mariana, and Andrade, Bruno B.
- Published
- 2024
- Full Text
- View/download PDF
3. A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction
- Author
-
Queiroz, Artur T. L., Vinhaes, Caian L., Fukutani, Eduardo R., Gupte, Akshay N., Kumar, Nathella Pavan, Fukutani, Kiyoshi F., Arriaga, María B., Sterling, Timothy R., Babu, Subash, Gaikwad, Sanjay, Karyakarte, Rajesh, Mave, Vidya, Paradhkar, Mandar, Viswanathan, Vijay, Gupta, Amita, Andrade, Bruno B., and Kornfeld, Hardy
- Published
- 2023
- Full Text
- View/download PDF
4. An integrative multi-omics approach to characterize interactions between tuberculosis and diabetes mellitus
- Author
-
Vinhaes, Caian L., Fukutani, Eduardo R., Santana, Gabriel C., Arriaga, María B., Barreto-Duarte, Beatriz, Araújo-Pereira, Mariana, Maggitti-Bezerril, Mateus, Andrade, Alice M.S., Figueiredo, Marina C., Milne, Ginger L., Rolla, Valeria C., Kristki, Afrânio L., Cordeiro-Santos, Marcelo, Sterling, Timothy R., Andrade, Bruno B., and Queiroz, Artur T.L.
- Published
- 2024
- Full Text
- View/download PDF
5. Severe viral lower respiratory tract infections in Brazilian children: Clinical features of a national cohort
- Author
-
Menezes, Rodrigo C., Ferreira, Isabella B.B., Sobral, Luciana, Garcia, Stefania L., Pustilnik, Hugo N., Araújo-Pereira, Mariana, and Andrade, Bruno B.
- Published
- 2024
- Full Text
- View/download PDF
6. Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial
- Author
-
Araújo-Pereira, Mariana, Krishnan, Sonya, Salgame, Padmini, Manabe, Yukari C., Hosseinipour, Mina C., Bisson, Gregory, Severe, Damocles Patrice, Rouzier, Vanessa, Leong, Samantha, Mave, Vidya, Sawe, Fredrick Kipyego, Siika, Abraham M., Kanyama, Cecilia, Dadabhai, Sufia S., Lama, Javier R., Valencia-Huamani, Javier, Badal-Faesen, Sharlaa, Lalloo, Umesh Gangaram, Naidoo, Kogieleum, Mohapi, Lerato, Kityo, Cissy, Andrade, Bruno B., and Gupta, Amita
- Published
- 2023
- Full Text
- View/download PDF
7. Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis: A multi-center prospective cohort study
- Author
-
Andrade, Alice M.S., Nascimento, Vanessa, Cubillos-Angulo, Juan Manuel, Malta-Santos, Hayna, Rebouças-Silva, Jéssica, Santos, Saulo R.N., Ramos, André, Brito, Pedro, Schmaltz, Carolina A.S., Costa, Alysson G., Sousa Garcia, Leandro, de Sousa Carvalho, Brenda K., de Loiola, Bruna P., Gomes-Silva, Adriano, Ignácio, Francine P., Lourenço, Maria C., Silva, Elisangela C., Mello, Mayla, Souza, Alexandra B., Barreto-Duarte, Beatriz, Rocha, Michael S., Benjamin, Aline, Moreira, Adriana S.R., de Oliveira, Jamile G., Cavalcante, Solange, Durovni, Betina, Lapa-e-Silva, José R., Araújo-Pereira, Mariana, Nogueira, Betânia M.F., Spener-Gomes, Renata, Carvalho, Anna C.C., Sant’Anna, Flávia Marinho, Figueiredo, Marina C., Turner, Megan M., Kritski, Afrânio L., Cordeiro-Santos, Marcelo, Rolla, Valeria C., Sterling, Timothy R., and Andrade, Bruno B.
- Published
- 2023
- Full Text
- View/download PDF
8. Determinants of losses in the tuberculosis infection cascade of care among children and adolescent contacts of pulmonary tuberculosis cases: A Brazilian multi-centre longitudinal study
- Author
-
Sobral, Luciana, Arriaga, María B., Souza, Alexandra B., Araújo-Pereira, Mariana, Barreto-Duarte, Beatriz, Sales, Caio, Rocha, Michael S., Benjamin, Aline, Moreira, Adriana S.R., de Oliveira, Jamile G., Carvalho, Anna Cristina, Spener-Gomes, Renata, Figueiredo, Marina C., Cavalcante, Solange, Durovni, Betina, Lapa-e-Silva, José R., Kritski, Afrânio L., Rolla, Valeria C., Sterling, Timothy R., Cordeiro-Santos, Marcelo, and Andrade, Bruno B.
- Published
- 2022
- Full Text
- View/download PDF
9. Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19
- Author
-
Hottz, Eugenio D., Martins-Gonçalves, Remy, Palhinha, Lohanna, Azevedo-Quintanilha, Isaclaudia G., de Campos, Mariana M., Sacramento, Carolina Q., Temerozo, Jairo R., Soares, Vinicius Cardoso, Dias, Suelen S. Gomes, Teixeira, Lívia, Castro, Ícaro, Righy, Cassia, Souza, Thiago Moreno L., Kurtz, Pedro, Andrade, Bruno B., Nakaya, Helder I., Monteiro, Robson Q., Bozza, Fernando A., and Bozza, Patrícia T.
- Published
- 2022
- Full Text
- View/download PDF
10. Possible sex difference in latent tuberculosis infection risk among close tuberculosis contacts
- Author
-
Wada, Paul Y., Costa, Allyson G., Araújo-Pereira, Mariana, Barreto-Duarte, Beatriz, Souza, Alexandra B., Rocha, Michael S., Figueiredo, Marina C., Turner, Megan M., Rolla, Valeria C., Kritski, Afrânio L., Cordeiro-Santos, Marcelo, Andrade, Bruno B., Sterling, Timothy R., and Rebeiro, Peter F.
- Published
- 2022
- Full Text
- View/download PDF
11. The impact of body mass index on the prognostic performance of the Simplified Acute Physiology Score 3: A prospective cohort study
- Author
-
Ferreira, Isabella B.B., Menezes, Rodrigo C., Otero, Matheus L., Carmo, Thomas A., Agareno, Gabriel A., Telles, Gabriel P., Fahel, Bruno V.B., Arriaga, María B., Fukutani, Kiyoshi F., Neto, Licurgo Pamplona, Agareno, Sydney, Akrami, Kevan M., Filgueiras Filho, Nivaldo M., and Andrade, Bruno B.
- Published
- 2022
- Full Text
- View/download PDF
12. Persistent dysglycemia is associated with unfavorable treatment outcomes in patients with pulmonary tuberculosis from Peru
- Author
-
Calderon, Roger I., Arriaga, María B., Aliaga, Juan G., Barreda, Nadia N., Sanabria, Oswaldo M., Barreto-Duarte, Beatriz, Franco, João Pedro Duarte, Lecca, Leonid, Andrade, Bruno B., Carvalho, Anna Cristina Calçada, and Kritski, Afrânio L.
- Published
- 2022
- Full Text
- View/download PDF
13. Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study.
- Author
-
Barreto-Duarte, Beatriz, Villalva-Serra, Klauss, Miguez-Pinto, João P, Araújo-Pereira, Mariana, Campos, Vanessa M S, Rosier, Gabriela, Nogueira, Betânia M F, Queiroz, Artur T L, Rolla, Valeria C, Cordeiro-Santos, Marcelo, Kritski, Afrânio L, Martinez, Leonardo, Rebeiro, Peter F, Sterling, Timothy R, Rodrigues, Moreno M, and Andrade, Bruno B
- Subjects
PATIENT compliance ,TREATMENT effectiveness ,ODDS ratio ,REGRESSION analysis ,TUBERCULOSIS ,DIRECTLY observed therapy - Abstract
Background Adherence to anti-tuberculosis treatment (ATT) in Brazil remains a challenge in achieving the goals set by the World Health Organization (WHO). Patients who are lost to follow-up during treatment pose a significant public health problem. This study aimed to investigate the factors associated with unfavorable ATT outcomes among those undergoing retreatment in Brazil. Methods We conducted an observational study of patients aged ≥18 years with tuberculosis (TB) reported to the Brazilian National Notifiable Disease Information System between 2015 and 2022. Clinical and epidemiologic variables were compared between the study groups (new cases and retreatment). Regression models identified variables associated with unfavorable outcomes. Results Among 743 823 reported TB cases in the study period, 555 632 cases were eligible, consisting of 462 061 new cases and 93 571 undergoing retreatments (44 642 recurrent and 48 929 retreatments after loss to follow-up [RLTFU]). RLTFU (odds ratio [OR], 3.96 [95% confidence interval {CI}, 3.83–4.1]) was a significant risk factor for any type of unfavorable ATT. Furthermore, RLTFU (OR, 4.93 [95% CI, 4.76–5.11]) was the main risk factor for subsequent LTFU. For death, aside from advanced age, living with HIV (OR, 6.28 [95% CI, 6.03–6.54]) was the top risk factor. Conclusions Retreatment is a substantial risk factor for unfavorable ATT outcomes, especially after LTFU. The rates of treatment success in RLTFU are distant from the WHO End TB Strategy targets throughout Brazil. These findings underscore the need for targeted interventions to improve treatment adherence and outcomes in persons who experience RLTFU. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. The effect of previous SARSCoV-2 infection on systemic immune responses in individuals with tuberculosis.
- Author
-
Xavier, Mariana S., Araujo-Pereira, Mariana, de Oliveira, Quezia M., Sant’Anna, Flavia M., Ridolfi, Felipe M., de Andrade, Alice M. S., Figueiredo, Marina C., Sterling, Timothy R., Gordhan, Bhavna G., Kana, Bavesh D., Andrade, Bruno B., Rolla, Valeria C., and Gomes-Silva, Adriano
- Subjects
IMMUNE response ,MYCOBACTERIUM tuberculosis ,TUBERCULOSIS ,SYMPTOMS ,INFECTION - Abstract
Background: The impact of previous SARS-CoV-2 infection on the systemic immune response during tuberculosis (TB) disease has not been explored. Methods: An observational, cross-sectional cohort was established to evaluate the systemic immune response in persons with pulmonary tuberculosis with or without previous SARS-CoV-2 infection. Those participants were recruited in an outpatient referral clinic in Rio de Janeiro, Brazil. TB was defined as a positive Xpert-MTB/RIF Ultra and/or a positive culture of Mycobacterium tuberculosis from sputum. Stored plasma was used to perform specific serology to identify previous SARS-CoV-2 infection (TB/Prex-SCoV-2 group) and confirm the noninfection of the tuberculosis group (TB group). Plasmatic cytokine/chemokine/ growth factor profiling was performed using Luminex technology. Tuberculosis severity was assessed by clinical and laboratory parameters. Participants from TB group (4.55%) and TB/Prex-SCoV-2 (0.00%) received the complete COVID19 vaccination. Results: Among 35 participants with pulmonary TB, 22 were classified as TB/ Prex-SCoV-2. The parameters associated with TB severity, together with hematologic and biochemical data were similar between the TB and TB/PrexSCoV-2 groups. Among the signs and symptoms, fever and dyspnea were significantly more frequent in the TB group than the TB/Prex-SCoV-2 group (p < 0,05). A signature based on lower amount of plasma EGF, G-CSF, GM-CSF, IFN-a2, IL-12(p70), IL-13, IL-15, IL-17, IL-1b, IL-5, IL-7, and TNF-b was observed in the TB/Prex-SCoV-2 group. In contrast, MIP-1b was significantly higher in the TB/Prex-SCoV-2 group than the TB group. Conclusion: TB patients previously infected with SARS-CoV-2 had an immunomodulation that was associated with lower plasma concentrations of soluble factors associated with systemic inflammation. This signature was associated with a lower frequency of symptoms such as fever and dyspnea but did not reflect significant differences in TB severity parameters observed at baseline. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Machine learning algorithms using national registry data to predict loss to follow-up during tuberculosis treatment.
- Author
-
Rodrigues, Moreno M. S., Barreto-Duarte, Beatriz, Vinhaes, Caian L., Araújo-Pereira, Mariana, Fukutani, Eduardo R., Bergamaschi, Keityane Bone, Kristki, Afrânio, Cordeiro-Santos, Marcelo, Rolla, Valeria C., Sterling, Timothy R., Queiroz, Artur T. L., and Andrade, Bruno B.
- Subjects
MACHINE learning ,MEDICAL personnel ,DISEASE risk factors ,TUBERCULOSIS ,PATIENT compliance - Abstract
Background: Identifying patients at increased risk of loss to follow-up (LTFU) is key to developing strategies to optimize the clinical management of tuberculosis (TB). The use of national registry data in prediction models may be a useful tool to inform healthcare workers about risk of LTFU. Here we developed a score to predict the risk of LTFU during anti-TB treatment (ATT) in a nationwide cohort of cases using clinical data reported to the Brazilian Notifiable Disease Information System (SINAN). Methods: We performed a retrospective study of all TB cases reported to SINAN between 2015 and 2022; excluding children (< 18 years-old), vulnerable groups or drug-resistant TB. For the score, data before treatment initiation were used. We trained and internally validated three different prediction scoring systems, based on Logistic Regression, Random Forest, and Light Gradient Boosting. Before applying our models we splitted our data into training (~ 80% data) and test (~ 20%) sets, and then compared the model metrics using the test data set. Results: Of the 243,726 cases included, 41,373 experienced LTFU whereas 202,353 were successfully treated. The groups were different with regards to several clinical and sociodemographic characteristics. The directly observed treatment (DOT) was unbalanced between the groups with lower prevalence in those who were LTFU. Three models were developed to predict LTFU using 8 features (prior TB, drug use, age, sex, HIV infection and schooling level) with different score composition approaches. Those prediction scoring systems exhibited an area under the curve (AUC) ranging between 0.71 and 0.72. The Light Gradient Boosting technique resulted in the best prediction performance, weighting specificity and sensitivity. A user-friendly web calculator app was developed (https://tbprediction.herokuapp.com/) to facilitate implementation. Conclusions: Our nationwide risk score predicts the risk of LTFU during ATT in Brazilian adults prior to treatment commencement utilizing schooling level, sex, age, prior TB status, and substance use (drug, alcohol, and/or tobacco). This is a potential tool to assist in decision-making strategies to guide resource allocation, DOT indications, and improve TB treatment adherence. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Zika-exposed microcephalic neonates exhibit higher degree of inflammatory imbalance in cerebrospinal fluid
- Author
-
Nascimento-Carvalho, Gustavo C., Nascimento-Carvalho, Eduardo C., Ramos, Clara L., Vilas-Boas, Ana-Luisa, Moreno-Carvalho, Otávio A., Vinhaes, Caian L., Barreto-Duarte, Beatriz, Queiroz, Artur T. L., Andrade, Bruno B., and Nascimento-Carvalho, Cristiana M.
- Published
- 2021
- Full Text
- View/download PDF
17. The influence of single nucleotide polymorphisms of NOD2 or CD14 on the risk of Mycobacterium tuberculosis diseases: a systematic review
- Author
-
Cubillos-Angulo, Juan M., Fernandes, Catarina D., Araújo, Davi N., Carmo, Cristinna A., Arriaga, María B., and Andrade, Bruno B.
- Published
- 2021
- Full Text
- View/download PDF
18. The role of ESAT-6 in tuberculosis immunopathology.
- Author
-
Passos, Beatriz B. S., Araújo-Pereira, Mariana, Vinhaes, Caian L., Amaral, Eduardo P., and Andrade, Bruno B.
- Subjects
IMMUNOPATHOLOGY ,TUBERCULOSIS ,MYCOBACTERIUM tuberculosis ,DISEASE progression ,IMMUNE system - Abstract
Despite major global efforts to eliminate tuberculosis, which is caused by Mycobacterium tuberculosis (Mtb), this disease remains as a major plague of humanity. Several factors associated with the host and Mtb interaction favor the infection establishment and/or determine disease progression. The Early Secreted Antigenic Target 6 kDa (ESAT-6) is one of the most important and well-studied mycobacterial virulence factors. This molecule has been described to play an important role in the development of tuberculosis-associated pathology by subverting crucial components of the host immune responses. This review highlights the main effector mechanisms by which ESAT-6 modulates the immune system, directly impacting cell fate and disease progression. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in Brazil.
- Author
-
Ridolfi, Felipe, Amorim, Gustavo, Peetluk, Lauren S, Haas, David W, Staats, Cody, Araújo-Pereira, Mariana, Cordeiro-Santos, Marcelo, Kritski, Afrânio L, Figueiredo, Marina C, Andrade, Bruno B, Rolla, Valeria C, Sterling, Timothy R, and Consortium, for the Regional Prospective Observational Research in Tuberculosis (RePORT)–Brazil
- Abstract
Background Tuberculosis (TB) treatment–related adverse drug reactions (TB-ADRs) can negatively affect adherence and treatment success rates. Methods We developed prediction models for TB-ADRs, considering participants with drug-susceptible pulmonary TB who initiated standard TB therapy. TB-ADRs were determined by the physician attending the participant, assessing causality to TB drugs, the affected organ system, and grade. Potential baseline predictors of TB-ADR included concomitant medication (CM) use, human immunodeficiency virus (HIV) status, glycated hemoglobin (HbA1c), age, body mass index (BMI), sex, substance use, and TB drug metabolism variables (NAT2 acetylator profiles). The models were developed through bootstrapped backward selection. Cox regression was used to evaluate TB-ADR risk. Results There were 156 TB-ADRs among 102 of the 945 (11%) participants included. Most TB-ADRs were hepatic (n = 82 [53%]), of moderate severity (grade 2; n = 121 [78%]), and occurred in NAT2 slow acetylators (n = 62 [61%]). The main prediction model included CM use, HbA1c, alcohol use, HIV seropositivity, BMI, and age, with robust performance (c-statistic = 0.79 [95% confidence interval {CI},.74–.83) and fit (optimism-corrected slope and intercept of −0.09 and 0.94, respectively). An alternative model replacing BMI with NAT2 had similar performance. HIV seropositivity (hazard ratio [HR], 2.68 [95% CI, 1.75–4.09]) and CM use (HR, 5.26 [95% CI, 2.63–10.52]) increased TB-ADR risk. Conclusions The models, with clinical variables and with NAT2 , were highly predictive of TB-ADRs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. The heroic journey of young Brazilian scientists: challenges and opportunities
- Author
-
Araújo-Pereira, Mariana and Andrade, Bruno B.
- Published
- 2024
- Full Text
- View/download PDF
21. Isoniazid Monoresistance and Antituberculosis Treatment Outcome in Persons With Pulmonary Tuberculosis in Brazil.
- Author
-
Araújo-Pereira, Mariana, Arriaga, María B, Carvalho, Anna Cristina C, Spener-Gomes, Renata, Schmaltz, Carolina A S, Nogueira, Betânia M F, Figueiredo, Marina C, Turner, Megan M, Cordeiro-Santos, Marcelo, Rolla, Valeria C, Sterling, Timothy R, Andrade, Bruno B, Kritski, Afrânio L, and Consortium, for the Regional Prospective Observational Research for Tuberculosis (RePORT)-Brazil
- Subjects
TUBERCULOSIS ,ISONIAZID ,TREATMENT effectiveness ,LOGISTIC regression analysis ,ODDS ratio - Abstract
Background The high burden of drug-resistant tuberculosis (TB) is a problem to achieve the goals of the End TB Strategy by 2035. Whether isoniazid monoresistance (Hr) affects anti-TB treatment (ATT) outcomes remains unknown in high-burden countries. Methods We evaluated determinants of ATT outcome among pulmonary TB cases reported to the National Notifiable Disease Information System (SINAN) between June 2015 and June 2019, according to drug sensitivity testing (DST) results. Binomial logistic regression models were employed to evaluate whether Hr was associated with an unfavorable ATT outcome: death or failure, compared to cure or treatment completion. Results Among 60 804 TB cases reported in SINAN, 21 197 (34.9%) were included in the study. In this database, the frequency of unfavorable outcomes was significantly higher in those with Hr in contrast to isoniazid-sensitive persons with pulmonary TB (9.1% vs 3.05%; P <.001). Using a binomial logistic regression model, Hr was independently associated with unfavorable outcomes (odds ratio, 3.34 [95% confidence interval, 2.06–5.40]; P <.001). Conclusions Hr detected prior to ATT was predictive of unfavorable outcomes at the national level in Brazil. Our data reinforce the need for high-TB-burden countries to prioritize DST to detect Hr. Effective treatment regimens for Hr-TB are needed to improve outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Influence of dietary pattern on anti-tuberculosis treatment outcomes in persons with dysglycemia: a Peruvian prospective cohort study.
- Author
-
Arriaga, María B., Araújo-Pereira, Mariana, Andrade, Vanessa M. B., Queiroz, Artur T. L., Fernandes, Catarina D., Sales, Caio, Gonzalo Aliaga, Juan, Shivakoti, Rupak, Lecca, Leonid, Calderon, Roger I., and Andrade, Bruno B.
- Published
- 2023
- Full Text
- View/download PDF
23. UMA ABORDAGEM MULTI-OMICA INTEGRATIVA PARA CARACTERIZAR A INTERAÇÃO ENTRE TUBERCULOSE E DIABETES MELLITUS
- Author
-
Vinhaes, Caian L., Fukutani, Eduardo R., Queiroz, Artur T.L., and Andrade, Bruno B.
- Published
- 2023
- Full Text
- View/download PDF
24. O SOM DO RNA SILENCIOSO: O PAPEL DOS LNCRNAS NA INTERAÇÃO TUBERCULOSE-DIABETES
- Author
-
Vinhaes, Caian L., Fukutani, Eduardo R., Araujo-Pereira, Mariana, Queiroz, Artur T.L., and Andrade, Bruno B.
- Published
- 2023
- Full Text
- View/download PDF
25. Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis: A multi-center prospective cohort study.
- Author
-
Araújo-Pereira, Mariana, Nogueira, Betânia M.F., Spener-Gomes, Renata, Carvalho, Anna C.C., Sant'Anna, Flávia Marinho, Figueiredo, Marina C., Turner, Megan M., Kritski, Afrânio L., Cordeiro-Santos, Marcelo, Rolla, Valeria C., Sterling, Timothy R., and Andrade, Bruno B.
- Abstract
Tuberculosis (TB) remains a major plague of humanity. People with TB (PWTB) are commonly anemic. Here, we assessed whether the severity of anemia in PWTB prior to anti-TB treatment (ATT) was a risk factor for an unfavorable outcome. Patients ≥ 18 years old with culture-confirmed drug-susceptible pulmonary TB enrolled between 2015 and 2019 in a multi-center Brazilian cohort were followed for up to 24 months and classified according to anemia severity (mild, moderate, and severe), based on hemoglobin levels. A multinomial logistic regression model was employed to assess whether anemia was associated with unfavorable outcome (death, failure, loss to follow-up, regimen modification or relapse), compared to treatment success (cure or treatment completion). Among 786 participants who met inclusion criteria, 441 (56 %) were anemic at baseline. Patients with moderate/severe anemia were more HIV-seropositive, as well as more symptomatic and had higher frequencies of unfavorable outcomes compared to the other groups. Moderate/severe anemia (adjusted OR [aOR]: 7.80, 95 %CI:1.34–45.4, p = 0.022) was associated with death independent of sex, age, BMI, HIV and glycemic status. Moderate/severe anemia prior to ATT was a significant risk factor for death. Such patients should be closely monitored given the high risk of unfavorable ATT outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Interplay between systemic inflammation, anemia, and mycobacterial dissemination and its impact on mortality in TB-associated HIV: a prospective cohort study.
- Author
-
Araújo-Pereira, Mariana, Schutz, Charlotte, Barreto-Duarte, Beatriz, Barr, David, Villalva-Serra, Klauss, Vinhaes, Caian L., Ward, Amy, Meintjes, Graeme, and Andrade, Bruno B.
- Subjects
IMMUNE reconstitution inflammatory syndrome ,ANEMIA ,COHORT analysis ,HIV-positive persons ,LONGITUDINAL method ,DISEASE risk factors - Abstract
Introduction: Anemia frequently affects people living with HIV (PLHIV). Nevertheless, the impact of anemia on treatment outcomes of patients with HIV-associated tuberculosis (TB) and the underlying molecular profiles are not fully characterized. The aim of this study was to investigate the interplay between anemia, the systemic inflammatory profile, dissemination of TB and death in HIV-TB patients in an ad hoc analysis of results from a prospective cohort study. Methods: 496 hospitalized PLHIV ≥18 years old, with CD4 count <350 cells/μL and high clinical suspicion of new TB infection were enrolled in Cape Town between 2014-2016. Patients were classified according to anemia severity in non-anemic, mild, moderate, or severe anemia. Clinical, microbiologic, and immunologic data were collected at baseline. Hierarchical cluster analysis, degree of inflammatory perturbation, survival curves and C-statistics analyses were performed. Results: Through the analysis of several clinical and laboratory parameters, we observed that those with severe anemia exhibited greater systemic inflammation, characterized by high concentrations of IL-8, IL-1RA and IL-6. Furthermore, severe anemia was associated with a higher Mtb dissemination score and a higher risk of death, particularly within 7 days of admission. Most of the patients who died had severe anemia and had a more pronounced systemic inflammatory profile. Discussion: Therefore, the results presented here reveal that severe anemia is associated with greater TB dissemination and increased risk of death in PLHIV. Early identification of such patients through measurement of Hb levels may drive closer monitoring to reduce mortality. Future investigations are warranted to test whether early interventions impact survival of this vulnerable population. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Severe anemia in persons with HIV is associated with inflammation, risk of IRIS and death
- Author
-
Araújo-Pereira, Mariana, Sheikh, Virginia, Sereti, Irini, Barreto -Duarte, Arriaga, María B, Tibúrcio, Rafael, Pinto-De-Almeida, Manuella, Wang, Jing, Rupert, Adam, Shaffer, Doug, Jintanat Ananworanich, Nittaya Phanuphak, and Andrade, Bruno B
- Published
- 2022
- Full Text
- View/download PDF
28. Tuberculosis treatment outcomes of diabetic and non-diabetic TB/HIV co-infected patients: A nationwide observational study in Brazil
- Author
-
Villalva-Serra, Klauss, Barreto-Duarte, Beatriz, Nunes, Vanessa M., Menezes, Rodrigo C., Rodrigues, Moreno M. S., Queiroz, Artur T. L., Arriaga, María B., Cordeiro-Santos, Marcelo, Kritski, Afrânio L., Sterling, Timothy R., Araújo-Pereira, Mariana, and Andrade, Bruno B.
- Subjects
tuberculosis ,diabetes ,treatment outcome ,HIV ,General Medicine ,Antiretroviral therapy (ART) - Abstract
BackgroundTuberculosis (TB) is a worldwide public health problem, especially in countries that also report high numbers of people living with HIV (PLWH) and/or diabetes mellitus (DM). However, the unique features of persons with TB-HIV-DM are incompletely understood. This study compared anti-TB treatment (ATT) outcomes of diabetic and non-diabetic TB/HIV co-infected patients.MethodsA nationwide retrospective observational investigation was performed with data from the Brazilian Tuberculosis Database System among patients reported to have TB-HIV co-infection between 2014 and 2019. This database includes all reported TB cases in Brazil. Exploratory and association analyses compared TB treatment outcomes in DM and non-DM patients. Unfavorable outcomes were defined as death, treatment failure, loss to follow-up or recurrence. Multivariable stepwise logistic regressions were used to identify the variables associated with unfavorable ATT outcomes in the TB-HIV population.ResultsOf the 31,070 TB-HIV patients analyzed, 999 (3.2%) reported having DM. However, in these TB-HIV patients, DM was not associated with any unfavorable treatment outcome [adjusted Odds Ratio (aOR): 0.97, 95% CI: 0.83–1.12, p = 0.781]. Furthermore, DM was also not associated with any specific type of unfavorable outcome in this study. In both the TB-HIV group and the TB-HIV-DM subpopulation, use of alcohol, illicit drugs and tobacco, as well as non-white ethnicity and prior TB were all characteristics more frequently observed in persons who experienced an unfavorable ATT outcome.ConclusionDM is not associated with unfavorable TB treatment outcomes in persons with TB-HIV, including death, treatment failure, recurrence and loss to follow up. However, consumption habits, non-white ethnicity and prior TB are all more frequently detected in those with unfavorable outcomes in both TB-HIV and TB-HIV-DM patients.
- Published
- 2022
29. Assessment of the risk of burnout and its associated factors in healthcare professionals during the COVID-19 pandemic: A prospective cohort study.
- Author
-
Silva, Rebeca R. C., Menezes, Rodrigo C., Garcia, Stefania L., Pustilnik, Hugo N., Ferreira, Isabella B. B., Aguiar, Kaique V. C. S., Filgueiras Filho, Nivaldo M., Araújo-Pereira, Mariana, and Andrade, Bruno B.
- Subjects
COVID-19 pandemic ,MEDICAL personnel ,MENTAL health personnel ,PSYCHOLOGICAL burnout ,RISK assessment - Abstract
Introduction: The COVID-19 pandemic resulted in tremendous physical and psychological pressure on healthcare professionals, especially on those working in intensive care units (ICUs) and Emergency Departments (EDs). The present study intended to characterize the profile of these professionals which is associated with burnout and determine the potential predictors of such condition. Methods: A Prospective cohort study was carried out in a tertiary hospital between March 2020 and March 2021, in Salvador, Brazil. A standardized and validated version of the Oldenburg Burnout inventory (OLBI) was applied to assess risk of burnout together with data forms designed to collect information on sociodemographic characteristics and religious beliefs. ICU and ED healthcare professionals were evaluated during off-hours at two distinct periods of the COVID-19 pandemic, in 2020 and in 2021. Differences in the results obtained from each study participant between the timepoints were compared. A binary logistic regression analysis was performed to identify the predictors of burnout development independent of other confounding factors. Results: Seventy-seven healthcare professionals with a median age of 33 (interquartile range [IQR]: 31-37.5) years and predominantly female (72.7%; n = 56) were enrolled. There were 62 professionals at risk of developing burnout through the OLBI. Those had a median age of 33 (IQR: 31-37) and female predominance (71%, n = 44). Disengagement and burnout were the only features which frequencies significantly changed over time, with increasing detection at the latest timepoint. Alcohol consumption was found to be an important risk factor for burnout development [adjusted odds ratio (aOR): 10.8 (95% CI: 1.8-64.2)]. Importantly, working in the ICU [aOR: 0.04 (95%CI: 0.01-0.32)] and the habit of praying daily [aOR: 0.07 (95%CI: 0.01-0.41)] were characteristics linked to reduced odds of burnout. Discussion: Disengagement substantially increased during the COVID-19 pandemic in healthcare professionals. Alcohol consumption favors the onset of burnout whereas habit of praying daily and working in the ICU are protective against such outcome. Institutional policies aimed at minimizing etilism may positively impact mental health of these professionals. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. Transcriptional Analysis for Tuberculosis in Pregnant Women From the PRegnancy Associated Changes In Tuberculosis Immunology (PRACHITi) Study.
- Author
-
Mathad, Jyoti S, Queiroz, Artur T L, Bhosale, Ramesh, Alexander, Mallika, Naik, Shilpa, Kulkarni, Vandana, Andrade, Bruno B, and Gupta, Amita
- Subjects
HIV infections ,SCIENTIFIC observation ,PREGNANT women ,CASE-control method ,TUBERCULOSIS ,LONGITUDINAL method - Abstract
A new tuberculosis (TB) diagnostic cartridge assay, which detects a 3-gene TB signature in whole blood, was not diagnostic in women with maternal TB disease in India (area under the curve [AUC] = 0.72). In a cohort of pregnant women, we identified a novel gene set for TB diagnosis (AUC = 0.97) and one for TB progression (AUC = 0.96). [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Diagnostic biomarkers for active tuberculosis: progress and challenges.
- Author
-
Nogueira, Betânia M F, Krishnan, Sonya, Barreto‐Duarte, Beatriz, Araújo‐Pereira, Mariana, Queiroz, Artur T L, Ellner, Jerrold J, Salgame, Padmini, Scriba, Thomas J, Sterling, Timothy R, Gupta, Amita, and Andrade, Bruno B
- Abstract
Tuberculosis (TB) is a leading cause of morbidity and mortality from a single infectious agent, despite being preventable and curable. Early and accurate diagnosis of active TB is critical to both enhance patient care, improve patient outcomes, and break Mycobacterium tuberculosis (Mtb) transmission cycles. In 2020 an estimated 9.9 million people fell ill from Mtb, but only a little over half (5.8 million) received an active TB diagnosis and treatment. The World Health Organization has proposed target product profiles for biomarker‐ or biosignature‐based diagnostics using point‐of‐care tests from easily accessible specimens such as urine or blood. Here we review and summarize progress made in the development of pathogen‐ and host‐based biomarkers for active TB diagnosis. We describe several unique patient populations that have posed challenges to development of a universal diagnostic TB biomarker, such as people living with HIV, extrapulmonary TB, and children. We also review additional limitations to widespread validation and utilization of published biomarkers. We conclude with proposed solutions to enhance TB diagnostic biomarker validation and uptake. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
32. Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary Tuberculosis.
- Author
-
Arriaga, María B., Karim, Farina, Queiroz, Artur T.L., Araújo-Pereira, Mariana, Barreto-Duarte, Beatriz, Sales, Caio, Moosa, Mahomed-Yunus S., Mazibuko, Matilda, Milne, Ginger L., Maruri, Fernanda, Henrique Serezani, Carlos, Koethe, John R., Figueiredo, Marina C., Kritski, Afrânio L., Cordeiro-Santos, Marcelo, Rolla, Valeria C., Sterling, Timothy R., Leslie, Alasdair, and Andrade, Bruno B.
- Abstract
Background: Oxidized lipid mediators such as eicosanoids play a central role in the inflammatory response associated with tuberculosis (TB) pathogenesis. Diabetes mellitus (DM) leads to marked changes in lipid mediators in persons with TB. However, the associations between diabetes-related changes in lipid mediators and clearance of M. tuberculosis (Mtb) among persons on anti-TB treatment (ATT) are unknown. Quantification of urinary eicosanoid metabolites can provide insights into the circulating lipid mediators involved in Mtb immune responses. Methods: We conducted a multi-site prospective observational study among adults with drug-sensitive pulmonary TB and controls without active TB; both groups had subgroups with or without dysglycemia at baseline. Participants were enrolled from RePORTBrazil (Salvador site) and RePORT-South Africa (Durban site) and stratified according to TB status and baseline glycated hemoglobin levels: a) TB-dysglycemia (n=69); b) TBnormoglycemia (n=64); c) non-TB/dysglycemia (n=31); d) non-TB/non-dysglycemia (n=29). We evaluated the following urinary eicosanoid metabolites: 11α-hydroxy-9,15- dioxo-2,3,4,5-tetranor-prostane-1,20-dioic acid (major urinary metabolite of prostaglandin E2, PGE-M), tetranor-PGE1 (metabolite of PGE2, TN-E), 9α-hydroxy11,15-dioxo-2,3,4,5-tetranor-prostane-1,20-dioic acid (metabolite of PGD2, PGD-M), 11-dehydro-thromboxane B2 (11dTxB2), 2,3-dinor-6-keto-PGF1α (prostaglandin I metabolite, PGI-M), and leukotriene E4 (LTE
4 ). Comparisons between the study groups were performed at three time points: before ATT and 2 and 6 months after initiating therapy. Results: PGE-M and LTE4 values were consistently higher at all three time-points in the TB-dysglycemia group compared to the other groups (p<0.001). In addition, there was a significant decrease in PGI-M and LTE4 levels from baseline to month 6 in the TBdysglycemia and TB-normoglycemia groups. Finally, TB-dysglycemia was independently associated with increased concentrations of PGD-M, PGI-M, and LTE4 at baseline in a multivariable model adjusting for age, sex, BMI, and study site. These associations were not affected by HIV status. Conclusion: The urinary eicosanoid metabolite profile was associated with TBdysglycemia before and during ATT. These observations can help identify the mechanisms involved in the pathogenesis of TB-dysglycemia, and potential biomarkers of TB treatment outcomes, including among persons with dysglycemia. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
33. Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical Trial.
- Author
-
Araújo-Pereira, Mariana, Barreto-Duarte, Beatriz, Arriaga, María B., Musselwhite, Laura W., Vinhaes, Caian L., Belaunzaran-Zamudio, Pablo F., Rupert, Adam, Montaner, Luis J., Lederman, Michael M., Sereti, Irini, Madero, Juan G. Sierra, and Andrade, Bruno B.
- Subjects
HIV-positive persons ,ANEMIA ,TUBERCULOSIS ,CLINICAL trials ,IMMUNE reconstitution inflammatory syndrome ,CD4 lymphocyte count - Abstract
People with HIV (PWH) are at increased risk of developing active tuberculosis (TB), and anemia is a common complication in both conditions. Anemia in TB patients has been linked to immune activation, levels of inflammatory biomarkers in blood, and risk for HIV disease progression and death. In this study we show that anemia was associated with a more pronounced inflammatory profile in HIV-TB coinfected persons in a cohort of 159 individuals with advanced HIV disease (CD4 count < 100 cells/µL) recruited as part of a randomized clinical trial (NCT00988780). A panel of plasma biomarkers was assessed on plasma obtained prior to combination antiretroviral therapy (cART) initiation. We performed a series of multidimensional analyses including clinical variables and concentrations of inflammatory biomarkers to profile systemic inflammation of PWH with and without anemia. We observed that TB participants presented with moderately lower levels of hemoglobin than non-TB participants. These participants also presented a higher Degree of Inflammatory Perturbation (DIP) score, related to increased levels of IFN-γ and TNF. The DIP was associated with TB coinfection and anemia before cART initiation. Future mechanistic studies are warranted to assess the determinants of such associations and the implications on treatment outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
34. Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIV.
- Author
-
Queiroz, Artur T. L., Araújo-Pereira, Mariana, Barreto-Duarte, Beatriz, Gomes-Silva, Adriano, Costa, Allyson G., Andrade, Alice M. S., Miguez-Pinto, João Pedro, Spener-Gomes, Renata, Souza, Alexandra B., Benjamin, Aline, Sant'Anna, Flavia, Figueiredo, Marina C., Mave, Vidya, Salgame, Padmini, Ellner, Jerrold J., Sterling, Timothy R., Cordeiro-dos-Santos, Marcelo, Andrade, Bruno B., and Rolla, Valeria C.
- Subjects
AIDS-related opportunistic infections ,MYCOBACTERIUM tuberculosis ,OPPORTUNISTIC infections ,TUBERCULOSIS ,GROWTH factors ,HIV-positive persons - Abstract
Introduction: Tuberculosis (TB) is a common opportunistic infection among people living with HIV. Diagnostic tests such as culture, Xpert-MTB-RIF, and ULTRA have low sensitivity in paucibacillary TB disease; a blood biomarker could improve TB diagnostic capabilities. We assessed soluble factors to identify biomarkers associated with TB among persons with advanced HIV. Methods: A case-control (1:1) study was conducted, with participants from Rio de Janeiro and Manaus, Brazil. People living with HIV presenting with CD4 count ≤100 cells/mm3 were eligible to participate. Cases had culture-confirmed TB (N=15) (positive for Mycobacterium tuberculosis [Mtb]); controls had HIV-infection only (N=15). Study visits included baseline, month 2 and end of TB therapy, during which samples of peripheral blood were obtained. A panel containing 29 biomarkers including cytokines, chemokines and growth factors was utilized to assess candidate biomarkers using Luminex technology in cryopreserved EDTA plasma samples. We used neural network analysis, based on machine learning, to identify biomarkers (single or in combination) that best distinguished cases from controls. Additional multi-dimensional analyses provided detailed profiling of the systemic inflammatory environment in cases and controls. Results: Median CD4 count and HIV-1 RNA load values were similar between groups at all timepoints. Persons with TB had lower body mass index (BMI) (median=19.6, Interquartile Range [IQR]=18.6-22.3) than controls (23.7; IQR: 21.8 = 25.5, p=0.004). TB coinfection was also associated with increased frequency of other comorbidities. The overall profile of plasma cytokines, chemokines and growth factors were distinct between the study groups at all timepoints. Plasma concentrations of IL-15 and IL-10 were on average lower in TB cases than in controls. When used in combination, such markers were able to discriminate between TB cases and controls with the highest degree of accuracy at each study timepoint. Conclusion: Among persons with advanced HIV, plasma concentrations of IL-15 and IL-10 can be used in combination to identify TB disease regardless of time on anti-TB treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
35. Leishmania infantum Defective in Lipophosphoglycan Biosynthesis Interferes With Activation of Human Neutrophils.
- Author
-
Quintela-Carvalho, Graziele, Goicochea, Astrid Madeleine Calero, Mançur-Santos, Vanessa, Viana, Sayonara de Melo, Luz, Yasmin da Silva, Dias, Beatriz Rocha Simões, Lázaro-Souza, Milena, Suarez, Martha, de Oliveira, Camila Indiani, Saraiva, Elvira M., Brodskyn, Cláudia I., Veras, Patrícia T., de Menezes, Juliana P.B., Andrade, Bruno B., Lima, Jonilson Berlink, Descoteaux, Albert, and Borges, Valéria M.
- Subjects
LEISHMANIASIS ,LEISHMANIA infantum ,NEUTROPHILS ,VISCERAL leishmaniasis ,LYSOSOMES ,REACTIVE oxygen species ,BIOSYNTHESIS ,INTRACELLULAR pathogens - Abstract
Visceral leishmaniasis (VL) is often associated with hematologic manifestations that may interfere with neutrophil response. Lipophosphoglycan (LPG) is a major molecule on the surface of Leishmania promastigotes, which has been associated with several aspects of the parasite–vector–host interplay. Here, we investigated how LPG from Leishmania (L.) infantum , the principal etiological agent of VL in the New World, influences the initial establishment of infection during interaction with human neutrophils in an experimental setting in vitro. Human neutrophils obtained from peripheral blood samples were infected with either the wild-type L. infantum (WT) strain or LPG-deficient mutant (∆lpg1). In this setting, ∆lpg1 parasites displayed reduced viability compared to WT L. infantum ; such finding was reverted in the complemented ∆lpg1 + LPG1 parasites at 3- and 6-h post-infection. Confocal microscopy experiments indicated that this decreased survival was related to enhanced lysosomal fusion. In fact, LPG-deficient L. infantum parasites more frequently died inside neutrophil acidic compartments, a phenomenon that was reverted when host cells were treated with Wortmannin. We also observed an increase in the secretion of the neutrophil collagenase matrix metalloproteinase-8 (MMP-8) by cells infected with ∆lpg1 L. infantum compared to those that were infected with WT parasites. Furthermore, collagen I matrix degradation was found to be significantly increased in ∆lpg1 parasite-infected cells but not in WT-infected controls. Flow cytometry analysis revealed a substantial boost in production of reactive oxygen species (ROS) during infection with either WT or ∆lpg1 L. infantum. In addition, killing of ∆lpg1 parasites was shown to be more dependent on the ROS production than that of WT L. infantum. Notably, inhibition of the oxidative stress with Apocynin potentially fueled ∆lpg1 L. infantum fitness as it increased the intracellular parasite viability. Thus, our observations demonstrate that LPG may be a critical molecule fostering parasite survival in human neutrophils through a mechanism that involves cellular activation and generation of free radicals. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
36. Frequency of CXCR3+ CD8+ T-Lymphocyte Subsets in Peripheral Blood Is Associated With the Risk of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Development in Advanced HIV Disease.
- Author
-
Tibúrcio, Rafael, Narendran, Gopalan, Barreto-Duarte, Beatriz, Queiroz, Artur T. L., Araújo-Pereira, Mariana, Anbalagan, Selvaraj, Nayak, Kaustuv, Ravichandran, Narayanan, Subramani, Rajasekaran, Antonelli, Lis R. V., Satagopan, Kumar, Anbalagan, Komathi, Porter, Brian O., Sher, Alan, Swaminathan, Soumya, Sereti, Irini, and Andrade, Bruno B.
- Subjects
IMMUNE reconstitution inflammatory syndrome ,LYMPHOCYTE subsets ,IMMUNOLOGIC memory ,T cells ,MIXED infections ,CHEMOKINE receptors - Abstract
Background: Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is a clinical aggravation of TB symptoms observed among a fraction of HIV coinfected patients shortly after the start of antiretroviral therapy (ART). Of note, TB-IRIS is characterized by exacerbated inflammation and tissue damage that occurs in response to the elevated production of CD4
+ T cell-derived IFN-γ. Nevertheless, the possible participation of CD8+ T cells in TB-IRIS development remains unclear. Methods: We performed a comprehensive assessment of the composition of CD8+ T cell memory subsets and their association with circulating inflammation-related molecules in TB-HIV coinfected patients initiating ART. Results: We found that TB-IRIS individuals display higher frequencies of Antigen-experienced CD8+ T cells during the onset of IRIS and that the levels of these cells positively correlate with baseline mycobacterial smear grade. TB-IRIS individuals exhibited higher frequencies of effector memory and lower percentages of naïve CD8+ T cells than their Non-IRIS counterparts. In both TB-IRIS and Non-IRIS patients, ART commencement was associated with fewer significant correlations among memory CD8+ T cells and cells from other immune compartments. Networks analysis revealed distinct patterns of correlation between each memory subset with inflammatory cytokines suggesting different dynamics of CD8+ T cell memory subsets reconstitution. TB-IRIS patients displayed lower levels of memory cells positive for CXCR3 (a chemokine receptor that plays a role in trafficking activated CD8+ T cells to the tissues) than Non-IRIS individuals before and after ART. Furthermore, we found that CXCR3+ naïve CD8+ T cells were inversely associated with the risk of TB-IRIS development. On the other hand, we noticed that the frequencies of CXCR3+ effector CD8+ T cells were positively associated with the probability of TB-IRIS development. Conclusion: Our data suggest that TB-IRIS individuals display a distinct profile of memory CD8+ T cell subsets reconstitution after ART initiation. Moreover, our data point to a differential association between the frequencies of CXCR3+ CD8+ T cells and the risk of TB-IRIS development. Collectively, our findings lend insights into the potential role of memory CD8+ T cells in TB-IRIS pathophysiology. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
37. Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.
- Author
-
Peetluk, Lauren S, Rebeiro, Peter F, Ridolfi, Felipe M, Andrade, Bruno B, Cordeiro-Santos, Marcelo, Kritski, Afranio, Durovni, Betina, Calvacante, Solange, Figueiredo, Marina C, Haas, David W, Liu, Dandan, Rolla, Valeria C, Sterling, Timothy R, and Network, Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil
- Subjects
TUBERCULOSIS prognosis ,DRUG therapy for tuberculosis ,HIV infections ,REFERENCE values ,REPORTING of diseases ,DRUG tolerance ,CONFIDENCE intervals ,TREATMENT failure ,SEVERITY of illness index ,ISONIAZID ,FORECASTING ,MIXED infections ,PREDICTION models ,DRUG resistance in microorganisms ,POPULATION health ,HEALTH care rationing ,EPIDEMIOLOGICAL research ,HIV - Abstract
Background Despite widespread availability of curative therapy, tuberculosis (TB) treatment outcomes remain suboptimal. Clinical prediction models can inform treatment strategies to improve outcomes. Using baseline clinical data, we developed a prediction model for unsuccessful TB treatment outcome and evaluated the incremental value of human immunodeficiency virus (HIV)–related severity and isoniazid acetylator status. Methods Data originated from the Regional Prospective Observational Research for Tuberculosis Brazil cohort, which enrolled newly diagnosed TB patients in Brazil from 2015 through 2019. This analysis included participants with culture-confirmed, drug-susceptible pulmonary TB who started first-line anti-TB therapy and had ≥12 months of follow-up. The end point was unsuccessful TB treatment: composite of death, treatment failure, regimen switch, incomplete treatment, or not evaluated. Missing predictors were imputed. Predictors were chosen via bootstrapped backward selection. Discrimination and calibration were evaluated with c-statistics and calibration plots, respectively. Bootstrap internal validation estimated overfitting, and a shrinkage factor was applied to improve out-of-sample prediction. Incremental value was evaluated with likelihood ratio–based measures. Results Of 944 participants, 191 (20%) had unsuccessful treatment outcomes. The final model included 7 baseline predictors: hemoglobin, HIV infection, drug use, diabetes, age, education, and tobacco use. The model demonstrated good discrimination (c-statistic = 0.77; 95% confidence interval,.73–.80) and was well calibrated (optimism-corrected intercept and slope, –0.12 and 0.89, respectively). HIV-related factors and isoniazid acetylation status did not improve prediction of the final model. Conclusions Using information readily available at treatment initiation, the prediction model performed well in this population. The findings may guide future work to allocate resources or inform targeted interventions for high-risk patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
38. The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts.
- Author
-
Arriaga, María B, Rocha, Michael S, Nogueira, Betânia M F, Nascimento, Vanessa, Araújo-Pereira, Mariana, Souza, Alexandra B, Andrade, Alice M S, Costa, Alysson G, Gomes-Silva, Adriano, Silva, Elisangela C, Figueiredo, Marina C, Turner, Megan M, Durovni, Betina, Lapa-e-Silva, José R, Kritski, Afrânio L, Cavalcante, Solange, Rolla, Valeria C, Cordeiro-Santos, Marcelo, Sterling, Timothy R, and Andrade, Bruno B
- Subjects
MYCOBACTERIUM tuberculosis ,PREDIABETIC state ,TUBERCULOSIS ,HYPERGLYCEMIA ,COUGH ,DIABETES ,TUBERCULOSIS transmission ,TUBERCULOSIS epidemiology ,TUBERCULOSIS diagnosis ,INTERFERON gamma release tests ,RESEARCH ,RESEARCH methodology ,EVALUATION research ,INTERFERONS ,COMPARATIVE studies ,TUBERCULIN test ,RESEARCH funding ,CONTACT tracing ,LONGITUDINAL method - Abstract
Background: It is unknown whether dysglycemia is associated with Mycobacterium tuberculosis transmission.Methods: We assessed epidemiological and clinical characteristics of patients with culture-confirmed pulmonary tuberculosis and their close contacts, enrolled in a multicenter prospective cohort in Brazil. Contacts were investigated at baseline and 6 months after enrollment. QuantiFERON positivity at baseline and conversion (from negative to positive at month 6) were compared between subgroups of contacts according to glycemic status of persons with tuberculosis (PWTB) as diabetes mellitus (DM) or prediabetes. Multivariable mixed-effects logistic regression models were performed to test independent associations with baseline QuantiFERON positive and QuantiFERON conversion.Results: There were 592 PWTB (153 DM, 141 prediabetes, 211 normoglycemic) and 1784 contacts, of whom 658 were QuantiFERON-positive at baseline and 106 converters. Multivariable analyses demonstrated that tuberculosis-prediabetes cases, acid-fast bacilli-positive, pulmonary cavities, and living with someone who smoked were independently associated with QuantiFERON positive in contacts at baseline. DM, persistent cough, acid-fast bacilli-positive, and pulmonary cavities in tuberculosis source cases were associated with QuantiFERON conversion.Conclusions: Contacts of persons with pulmonary tuberculosis and dysglycemia were at increased risk of being QuantiFERON positive at baseline or month 6. Increased focus on such close contacts could improve tuberculosis control. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
39. Impact of HIV status on systemic inflammation during pregnancy.
- Author
-
Vyas, Pooja, Mathad, Jyoti S., Leu, Cheng-Shiun, Naik, Shilpa, Alexander, Mallika, Araújo-Pereira, Mariana, Kulkarni, Vandana, Deshpande, Prasad, Yadana, Su, Andrade, Bruno B., Bhosale, Ramesh, Kumar, Pavan, Babu, Subash, Gupta, Amita, Shivakoti, Rupak, and Araujo-Pereira, Mariana
- Published
- 2021
- Full Text
- View/download PDF
40. Dissecting disease tolerance in Plasmodium vivax malaria using the systemic degree of inflammatory perturbation.
- Author
-
Vinhaes, Caian L., Carmo, Thomas A., Queiroz, Artur T. L., Fukutani, Kiyoshi F., Araújo-Pereira, Mariana, Arriaga, María B., Lacerda, Marcus V. G., Barral-Netto, Manoel, and Andrade, Bruno B.
- Subjects
PLASMODIUM vivax ,SYMPTOMS ,MALARIA ,DIAGNOSIS ,PARASITEMIA - Abstract
Homeostatic perturbation caused by infection fosters two major defense strategies, resistance and tolerance, which promote the host's survival. Resistance relates to the ability of the host to restrict the pathogen load. Tolerance minimizes collateral tissue damage without directly affecting pathogen fitness. These concepts have been explored mechanistically in murine models of malaria but only superficially in human disease. Indeed, individuals infected with Plasmodium vivax may present with asymptomatic malaria, only mild symptoms, or be severely ill. We and others have reported a diverse repertoire of immunopathological events that potentially underly susceptibility to disease severity in vivax malaria. Nevertheless, the combined epidemiologic, clinical, parasitological, and immunologic features associated with defining the disease outcomes are still not fully understood. In the present study, we perform an extensive outlining of cytokines and inflammatory proteins in plasma samples from a cohort of individuals from the Brazilian Amazon infected with P. vivax and presenting with asymptomatic (n = 108) or symptomatic (n = 134) disease (106 with mild presentation and 28 with severe malaria), as well as from uninfected endemic controls (n = 128) to elucidate these gaps further. We employ highly multidimensional Systems Immunology analyses using the molecular degree of perturbation to reveal nuances of a unique profile of systemic inflammation and imbalanced immune activation directly linked to disease severity as well as with other clinical and epidemiologic characteristics. Additionally, our findings reveal that the main factor associated with severe cases of P. vivax infection was the number of symptoms, despite of a lower global inflammatory perturbation and parasitemia. In these participants, the number of symptoms directly correlated with perturbation of markers of inflammation and tissue damage. On the other hand, the main factor associated with non-severe infections was the parasitemia values, that correlated only with perturbation of inflammatory markers, such as IL-4 and IL-1β, with a relatively lower number of symptoms. These observations suggest that some persons present severe vivax regardless of pathogen burden and global inflammatory perturbation. Such patients are thus little tolerant to P. vivax infection and show higher susceptibility to disrupt homeostasis and consequently exhibit more clinical manifestations. Other persons are capable to tolerate higher parasitemia with lower inflammatory perturbation and fewer symptoms, developing non-severe malaria. The analytical approach presented here has capability to define in more details the determinants of disease tolerance in vivax malaria. Author summary: Plasmodium vivax infection can result in a broad spectrum of disease manifestations, ranging from asymptomatic malaria to severe life-threatening disease. Despite significant advances in the current understanding of the critical factors associated with the disease outcomes in vivax malaria, the immunopathological events responsible for the diversity of severe manifestations in the disease remain deeply unknown. Here, a large panel of cytokines/chemokines were assessed in plasma samples from a Brazilian cohort of P. vivax patients presenting with asymptomatic infection or symptomatic malaria at the time of diagnosis, as well as from uninfected endemic controls, to define the relationships between systemic inflammation, disease presentation, parasitemia, and epidemiologic characteristics. In-depth analyses using the molecular degree of perturbation were employed to reveal nuances of a unique profile of systemic inflammation and imbalanced immune activation directly linked to disease severity. Moreover, the discoveries diagrammed the occurrence of disease tolerance by narrowing down the interactions between the systemic degree of inflammatory perturbation and parasitemia values in vivax malaria patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
41. Dynamics of T-Lymphocyte Activation Related to Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in Persons With Advanced HIV.
- Author
-
Tibúrcio, Rafael, Barreto-Duarte, Beatriz, Naredren, Gopolan, Queiroz, Artur T. L., Anbalagan, Selvaraj, Nayak, Kaustuv, Ravichandran, Narayanan, Subramani, Rajasekaran, Antonelli, Lis R. V., Satagopan, Kumar, Anbalagan, Komathi, Porter, Brian O., Sher, Alan, Swaminathan, Soumya, Sereti, Irini, and Andrade, Bruno B.
- Subjects
IMMUNE reconstitution inflammatory syndrome ,CYTOTOXIC T cells ,T cells ,LYMPHOCYTE transformation ,HIV - Abstract
Most persons living with HIV (PLWH) experience a significant restoration of their immunity associated with successful inhibition of viral replication after antiretroviral therapy (ART) initiation. Nevertheless, with the robust quantitative and qualitative restoration of CD4
+ T-lymphocytes, a fraction of patients co-infected with tuberculosis develop immune reconstitution inflammatory syndrome (TB-IRIS), a dysregulated inflammatory response that can be associated with significant tissue damage. Several studies underscored the role of adaptive immune cells in IRIS pathogenesis, but to what degree T lymphocyte activation contributes to TB-IRIS development remains largely elusive. Here, we sought to dissect the phenotypic landscape of T lymphocyte activation in PLWH coinfected with TB inititating ART, focusing on characterization of the profiles linked to development of TB-IRIS. We confirmed previous observations demonstrating that TB-IRIS individuals display pronounced CD4+ lymphopenia prior to ART initiation. Additionally, we found an ART-induced increase in T lymphocyte activation, proliferation and cytotoxicity among TB-IRIS patients. Importantly, we demonstrate that TB-IRIS subjects display higher frequencies of cytotoxic CD8+ T lymphocytes which is not affected by ART. Moreover, These patients exhibit higher levels of activated (HLA-DR+ ) and profilerative (Ki-67+ ) CD4+ T cells after ART commencenment than their Non-IRIS counterparts. Our network analysis reveal significant negative correlations between Total CD4+ T cells counts and the frequencies of Cytotoxic CD8+ T cells in our study population which could suggest the existance of compensatory mechanisms for Mtb-infected cells elimination in the face of severe CD4+ T cell lymphopenia. We also investigated the correlation between T lymphocyte activation profiles and the abundance of several inflammatory molecules in plasma. We applied unsupervised machine learning techniques to predict and diagnose TB-IRIS before and during ART. Our analyses suggest that CD4+ T cell activation markers are good TB-IRIS predictors, whereas the combination of CD4+ and CD8+ T cells markers are better at diagnosing TB-IRIS patients during IRIS events Overall, our findings contribute to a more refined understanding of immunological mechanisms in TB-IRIS pathogenesis that may assist in new diagnostic tools and more targeted patient management. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
42. ADVERSE DRUG REACTIONS ON TB TREATMENT: A PREDICTION MODEL INCLUDING HIV AND HBA1C.
- Author
-
Ridolfi, Felipe, Peetluk, Lauren, Amorim, Gustavo, Araújo-Pereira, Mariana, Cordeiro-Santos, Marcelo, Kritski, Afranio, Figueiredo, Marina, Andrade, Bruno B., Rolla, Valeria, and Sterling, Timothy R.
- Published
- 2023
43. TRAJECTORY OF POST-COVID NEUROCOGNITIVE RECOVERY IN PEOPLE LIVING WITH AND WITHOUT HIV.
- Author
-
Dziarski, Alisha, Gallego Marquez, Nuria, Jamal, Armaan, Walch, Samantha N., Romero, Arianna, Araújo-Pereira, Mariana, Queiroz, Artur T. L., Bunch, Christina, Zelaya, Ashley, Akasreku, Enam, Andrade, Bruno B., Peluso, Michael J., Landay, Alan, Vannorsdall, Tracy, and Antar, Annukka A. R.
- Published
- 2023
44. IMMUNE OMIC PROFILES TO DISTINGUISH TUBERCULOSIS AMONG ADVANCED HIV ADULTS IN INDIA.
- Author
-
Kulkarni, Vandana P., Queiroz, Artur T. L., Borse, Rohidas, Gupta, Amita, Andrade, Bruno B., Nawani, Neelu, Salgame, Padmini, and Mave, Vidya
- Published
- 2023
45. Factors Associated with Mortality in Critically Ill Patients Diagnosed with Hospital Acquired Infections [Erratum].
- Author
-
Otero, Matheus L, Menezes, Rodrigo C, Ferreira, Isabella B B, Issa, Francine L, Agareno, Gabriel, Carmo, Thomas Azevedo, Arriaga, María B, Fukutani, Kiyoshi F, Neto, Licurgo Pamplona, Agareno, Sydney, Filho, Nivaldo M Filgueiras, Akrami, Kevan M, and Andrade, Bruno B
- Subjects
CRITICALLY ill ,HOSPITAL patients ,MORTALITY ,INTENSIVE care units - Published
- 2021
- Full Text
- View/download PDF
46. CD4 T cells are rapidly depleted from tuberculosis granulomas following acute SIV co-infection.
- Author
-
Foreman, Taylor W., Nelson, Christine E., Kauffman, Keith D., Lora, Nickiana E., Vinhaes, Caian L., Dorosky, Danielle E., Sakai, Shunsuke, Gomez, Felipe, Fleegle, Joel D., Parham, Melanie, Perera, Shehan R., Lindestam Arlehamn, Cecilia S., Sette, Alessandro, Brenchley, Jason M., Queiroz, Artur T.L., Andrade, Bruno B., Kabat, Juraj, Via, Laura E., and Barber, Daniel L.
- Abstract
HIV /Mycobacterium tuberculosis (Mtb) co-infected individuals have an increased risk of tuberculosis prior to loss of peripheral CD4 T cells, raising the possibility that HIV co-infection leads to CD4 T cell depletion in lung tissue before it is evident in blood. Here, we use rhesus macaques to study the early effects of simian immunodeficiency virus (SIV) co-infection on pulmonary granulomas. Two weeks after SIV inoculation of Mtb-infected macaques, Mtb-specific CD4 T cells are dramatically depleted from granulomas, before CD4 T cell loss in blood, airways, and lymph nodes, or increases in bacterial loads or radiographic evidence of disease. Spatially, CD4 T cells are preferentially depleted from the granuloma core and cuff relative to B cell-rich regions. Moreover, live imaging of granuloma explants show that intralesional CD4 T cell motility is reduced after SIV co-infection. Thus, granuloma CD4 T cells may be decimated before many co-infected individuals experience the first symptoms of acute HIV infection. [Display omitted] • SIV rapidly replicates in Mtb granulomas of co-infected macaques • Granuloma CD4 T cells are depleted before those in blood, BAL, LNs, or spleen • CCR5
+ Eomes− Mtb-specific Th1 and Th1∗ cells in granulomas are preferentially depleted • SIV co-infection reduces motility of CD4 T cells in granulomas HIV-mediated destruction of CD4 T cells enhances susceptibility to Mycobacterium tuberculosis. Using macaques, Foreman et al. show that CD4 T cells in granulomas are depleted very rapidly after SIV co-infection, indicating that loss of immunity at the site of bacterial replication occurs long before signs of peripheral T cell depletion. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
47. Association of Maternal Inflammation During Pregnancy With Birth Outcomes and Infant Growth Among Women With or Without HIV in India.
- Author
-
Shafiq, Mehr, Mathad, Jyoti S., Naik, Shilpa, Alexander, Mallika, Yadana, Su, Araújo-Pereira, Mariana, Kulkarni, Vandana, Deshpande, Prasad, Kumar, Nathella Pavan, Babu, Subash, Andrade, Bruno B., Leu, Cheng-Shiun, Khwaja, Saltanat, Bhosale, Ramesh, Kinikar, Aarti, Gupta, Amita, and Shivakoti, Rupak
- Published
- 2021
- Full Text
- View/download PDF
48. Estimating optimal therapeutic drug levels of anti-tuberculosis medications based on treatment safety and effectiveness.
- Author
-
Amorim G, Haas DW, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Staats C, Hachey B, Turner M, Andrade BB, Rolla VC, and Sterling TR
- Abstract
Background: Therapeutic drug ranges (TDR) for standard anti-tuberculosis (TB) treatment have been determined based on expected drug levels at least 2 hours after taking the dose. In this study we constructed TDR for TB drug levels based on minimizing drug toxicity and maximizing treatment effectiveness., Methods: Participants were followed prospectively in the Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil observational cohort study. We focused on participants with culture-confirmed drug-susceptible pulmonary TB who underwent standard TB therapy. TDR were estimated for each TB drug separately: isoniazid (INH), rifampin (RIF), ethambutol (EMB), and pyrazinamide (PZA). TDR were defined as drug concentrations that were both safe and effective: safety was defined as the probability of having an ADR of at most 5%, while effectiveness was defined as a probability of at least 95% of not having either TB treatment failure or recurrence., Results: There were 765 plasma samples from 448 patients; 110 (24.6%) were people with HIV, 9 (2.0%) had a grade 3 or higher ADR, and 15 (3.3%) had treatment failure/recurrence. Higher drug concentrations of INH, RIF and EMB were associated with increased odds of having ADR. High concentrations of INH suggested protection against treatment failure/recurrence. Estimated therapeutic drug range for INH (2.3-8.2 µg/ml) and for RIF (0.5-7.5 µg/ml) differed from the currently recommended drug ranges (3-5 µg/ml and 8-24 µg/ml, respectively). Estimates for PZA and EMB were similar to the currently recommended values., Conclusions: Our estimated upper end TDR were higher for INH and lower for RIF compared to currently recommended ranges.
- Published
- 2024
- Full Text
- View/download PDF
49. Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil.
- Author
-
Piekos JA, Amorim G, Ridolfi F, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Andrade BB, Santos AR, Haas DW, Sterling TR, Rolla VC, and Edwards DRV
- Abstract
Tuberculosis (TB) treatment is highly effective, but response to therapy can vary by geography, race, and ethnicity. We assessed for differences in TB treatment response in a representative and heterogeneous Brazilian population. We estimated genetic ancestry proportion according to major ancestry groups (African, European, and Amerindian ancestry) in the Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil cohort. RePORT-Brazil is an observational prospective cohort study of individuals with newly-diagnosed, culture-confirmed, pulmonary TB. TB treatment outcomes that were attributed to TB treatment included Grade 2 or higher adverse drug reaction (ADR), Grade 3 or higher ADR, hepatic ADR, and failure/recurrence. Ancestry proportion was the main predictor in logistic regression for each outcome, with adjustments for candidate confounders. There were 941 pulmonary TB patients included in this study. We observed a decreased risk of Grade 2+ ADR when African ancestry proportion increased by 10% (Odds Ratio [OR] 0.41, 95% Confidence Interval [CI] 0.20 -0.85) and an increased risk for Grade 2+ ADR with increasing European ancestry (OR 2.84, 95% CI 1.47 - 5.48). We then performed the same analysis adding HIV status as an interaction term. The decreased risk for Grade 2+ ADR seen for African ancestry proportion did not hold for persons living with HIV; we observed increased risk for Grade 2+ ADR with increasing African ancestry proportion. There were no associations with Amerindian ancestry or for other treatment outcomes. In this Brazilian TB cohort, toxicity risk was associated with African and European ancestry, divergent, and affected by HIV. #RePORT-Brazil Consortium members include: Aline Benjamin and Flavia M. Sant'Anna Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil Jamile Garcia de Oliveira and João Marine Clínica de Saúde Rinaldo Delmare, Rio de Janeiro, Brazil Adriana Rezende and Anna Cristina Carvalho Secretaria de Saúde de Duque de Caxias, Rio de Janeiro, Brazil Michael Rocha and Betânia Nogueira Instituto Brasileiro para Investigação da Tuberculose, Fundação José Silveira, Salvador, Brazil Alexandra Brito and Renata Spener Fundação Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil Megan Turner Vanderbilt University Medical Center, Nashville, USA.
- Published
- 2024
- Full Text
- View/download PDF
50. Childhood obesity is associated with a high degree of metabolic disturbance in children from Brazilian semi-arid region.
- Author
-
Ferreira IBB, Gomes AN, Almeida IBC, Fernandes MD, Coutinho LF, Lago R, Menezes CA, Vianna NA, Oliveira RR, Fukutani ER, Menezes RC, Ladeia AM, and Andrade BB
- Subjects
- Humans, Child, Brazil epidemiology, Male, Female, Child, Preschool, Cross-Sectional Studies, C-Reactive Protein metabolism, C-Reactive Protein analysis, Metabolic Diseases blood, Metabolic Diseases epidemiology, Metabolic Diseases etiology, Biomarkers blood, Triglycerides blood, Pediatric Obesity blood, Pediatric Obesity epidemiology
- Abstract
Projected to impact 310 million children by the next decade, childhood obesity is linked to serious health issues like metabolic disturbance and cardiovascular diseases. This study introduces a novel approach for the integrated assessment of inflammatory, glycemic and lipid disorders in obese children in resources-limited settings and also identifies key factors contributing to these changes. Conducting a cross-sectional analysis of 231 children aged 5-12 years from public schools in Brazil's semi-arid region, the research involved collecting medical history, anthropometric measurements, and blood samples to analyze glycemic and lipid profiles, along with C-reactive protein levels. We used an adapted the Molecular Degree of Perturbation model to analyze deviations in metabolic markers from a healthy control group. Statistical analyses included Mann-Whitney and Fisher exact tests, backward logistic regression, and hierarchical cluster analysis. The study identified a direct and independent association between elevated Metabolic Disturbance Degree and both overweight and obesity in children, with significant differences in CRP, Triglycerides, and HDL levels noted between obese and healthy-weight groups. The findings highlight the critical need for early detection and comprehensive understanding of obesity-related changes to mitigate the severe health risks associated with childhood obesity., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.